Efforts to reduce drug availability through arrests, enforcement, and stopping production or trafficking are known as:

Prepare for the Immigration, Crime, and Legal Issues Exam. Test your knowledge with multiple choice questions and detailed explanations. Succeed with study resources and tips!

Multiple Choice

Efforts to reduce drug availability through arrests, enforcement, and stopping production or trafficking are known as:

Explanation:
The main idea here is distinguishing how drug policy aims to curb illegal drugs. This statement describes supply-side drug policy, which targets the availability of drugs by interrupting production, trafficking, and distribution through arrests, enforcement, seizures, and efforts to stop production or cross-border movement. In other words, it’s about cutting off what reaches the market rather than trying to reduce demand for drugs or lessen the harms of use. This differs from demand-side policy, which seeks to decrease demand through prevention, education, and treatment to reduce consumption. It also differs from harm reduction, which focuses on minimizing health risks and harms associated with use rather than eliminating supply. The last option isn’t a standard policy category. So the described efforts align with supply-side drug policy.

The main idea here is distinguishing how drug policy aims to curb illegal drugs. This statement describes supply-side drug policy, which targets the availability of drugs by interrupting production, trafficking, and distribution through arrests, enforcement, seizures, and efforts to stop production or cross-border movement. In other words, it’s about cutting off what reaches the market rather than trying to reduce demand for drugs or lessen the harms of use.

This differs from demand-side policy, which seeks to decrease demand through prevention, education, and treatment to reduce consumption. It also differs from harm reduction, which focuses on minimizing health risks and harms associated with use rather than eliminating supply. The last option isn’t a standard policy category. So the described efforts align with supply-side drug policy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy